Sequential Regimen with Thiotepa, Cyclophosphamide, Etoposide, Fludarabine and Busulfan in Allogeneic Stem Cell Transplantation for the Treatment of Relapsed and Refractory Hematological Malignancies
Relapsed / refractory leukemia and lymphoma (R/R, L/L) patients have a very poor prognosis despite all the well-known therapeutic strategies. Sequential conditioning followed by allogeneic stem cell transplantation (allo-SCT) provides an efficient disease control in those high risk patients.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Haidar El Darsa, Radwan Massoud, Ammar Zahreddine, Ali Bazarbachi, Jean El-Cheikh Source Type: research
More News: Cancer & Oncology | Hematology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Transplants